日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine

TAK-003的故事:塑造四价登革热疫苗研发的关键决策

Escudero, Ian; Gniel, Dieter; Biswal, Shibadas; Petri, Eckhardt; Perez, Gonzalo; Sharma, Mayuri; Weil, John; Wallace, Derek

Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.

成人肌肉注射二价(GI.1/GII.4)诺如病毒疫苗后免疫反应的持久性

Leroux-Roels Geert, Atmar Robert L, Cramer Jakob P, Escudero Ian, Borkowski Astrid

Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination

四价登革热疫苗(TAK-003)在既往接种过日本脑炎或黄热病疫苗的儿童中的有效性和安全性

Sirivichayakul, Chukiat; Biswal, Shibadas; Saez-Llorens, Xavier; López-Medina, Eduardo; Borja-Tabora, Charissa; Bravo, Lulu; Kosalaraksa, Pope; Alera, Maria Theresa; Reynales, Humberto; Rivera, Luis; Watanaveeradej, Veerachai; Yu, Delia; Espinoza, Felix; Dietze, Reynaldo; Fernando, LakKumar; Wickramasinghe, V Pujitha; Moreira, Edson Duarte Jr; Fernando, Asvini D; Gunasekera, Dulanie; Luz, Kleber; Venâncio da Cunha, Rivaldo; Oliveira, Ana Lucia; Rauscher, Martina; Fan, Huihao; Borkowski, Astrid; Escudero, Ian; Tuboi, Suely; Lloyd, Eric; Tricou, Vianney; Folschweiller, Nicolas; LeFevre, Inge; Vargas, Luis Martinez; Wallace, Derek

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study

黄热病疫苗 YF-17D 和四价登革热候选疫苗 TAK-003 同时及序贯接种的免疫原性和安全性:一项 3 期随机对照研究

Tricou, Vianney; Essink, Brandon; Ervin, John E; Turner, Mark; Escudero, Ian; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Borkowski, Astrid; Wallace, Derek